Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
LRRK2 levels in immune cells are increased in Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: October 11, 2015
Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.
Journal: Journal of Parkinson's disease
Published: July 26, 2014
Showing 1-2 of 2
Last Updated: 09/26/2026